AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6206093 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescreening Developmental Questionnaire (PDQ)
Number of subjects: 90
Study 6206093 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified PDQ (PDQ-M)
Number of subjects: 90
Study 6206093 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpern-Boll Developmental Profile II
Number of subjects: 90
Study 6206093 — intervention group
Group type: EXPERIMENTAL
Intervention: PDQ and PDQ-M
Number of subjects: 90
Study 30702789 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 26
Study 30702789 — intervention group
Group type: COMPARATOR
Intervention: Mineral Trioxide Aggregate
Number of subjects: 26
Study 30853260 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopically guided injections into the joint capsule (group 1)
Number of subjects: 125
Study 30853260 — intervention group
Group type: COMPARATOR
Intervention: Blind injections to the point of maximum tenderness using sham radiographs (group 2)
Number of subjects: 125
Study 30853260 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopically guided injections (group 1)
Number of subjects: 125
Study 30853260 — intervention group
Group type: COMPARATOR
Intervention: Blind injections (group 2)
Number of subjects: 125
Study 28791986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV) - sexual abuse
Number of subjects: 207
Study 28791986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV) - psychological abuse
Number of subjects: 207
Study 28791986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV) - danger assessment (femicide risk)
Number of subjects: 207
Study 28791986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence (IPV) - overall
Number of subjects: 207
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: General population (adults and children)
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascaris lumbricoides infection
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Hookworm infection
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichuris trichura infection
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Enterobius vermicularis infection in children
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonorchis sinensis infection
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of prevention and control of parasites
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy behaviors (washing hands before meal)
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy behaviors (washing hands after toilet)
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy behaviors (washing fruits and vegetables before eating)
Number of subjects: 9538
Study 26767263 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy behaviors (never drinking unboiled water)
Number of subjects: 9538
Study 23386552 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention hostel group (30 dyads)
Number of subjects: 59
Study 23386552 — intervention group
Group type: COMPARATOR
Intervention: Comparison hostels group (29 dyads)
Number of subjects: 59
Study 20851820 — intervention group
Group type: EXPERIMENTAL
Intervention: Venesection
Number of subjects: 198
Study 20851820 — intervention group
Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 198
Study 17609220 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glucocorticoid (20 mg of prednisolone)
Number of subjects: 14
Study 17609220 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 14
Study 16469157 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal-source foods supplementation
Number of subjects: 544
Study 12617741 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung recruitment manoeuvre after endotracheal suctioning
Number of subjects: 8
Study 12617741 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal suctioning without lung recruitment manoeuvre
Number of subjects: 8
Study 10684185 — intervention group
Group type: EXPERIMENTAL
Intervention: Early video-endoscopic procedures (9 patients)
Number of subjects: 52
Study 10684185 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (43 patients)
Number of subjects: 52
Study 9059095 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.0-mm reinforced tracheal tube (group F6)
Number of subjects: 60
Study 9059095 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal mask (group L)
Number of subjects: 60
Study 9059095 — intervention group
Group type: COMPARATOR
Intervention: 8.0-mm reinforced tracheal tube (group F8)
Number of subjects: 60
Study 8373609 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble inclinometer
Number of subjects: 50
Study 8373609 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental sodium (4 mg/kg) and succinylcholine (1 mg/kg)
Number of subjects: 50
Study 2425671 — intervention group
Group type: COMPARATOR
Intervention: Urokinase (UK) - 2.83 X 10(5) units by six-hour intravenous drip infusion
Number of subjects: 143
Study 2425671 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Urokinase (UK) and Dextran Sulfate (DS) - UK: 2.84 X 10(5) units and DS: 3000 mg for one day
Number of subjects: 143
Study 2425671 — intervention group
Group type: COMPARATOR
Intervention: Urokinase (UK) alone
Number of subjects: 143
Study 2425671 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Urokinase (UK) and Dextran Sulfate (DS)
Number of subjects: 143
Study 30589043 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib + TAP block + postoperative PCIA
Number of subjects: 80
Study 30589043 — intervention group
Group type: EXPERIMENTAL
Intervention: TAP block + postoperative PCIA
Number of subjects: 80
Study 30589043 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib + postoperative PCIA
Number of subjects: 80
Study 30589043 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal saline + postoperative PCIA)
Number of subjects: 80
Study 27664021 — intervention group
Group type: EXPERIMENTAL
Intervention: Phentermine
Number of subjects: 77
Study 27664021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 24906915 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 40
Study 24906915 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 40
Study 22668958 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco-emulsification cataract surgery
Number of subjects: 200
Study 22668958 — intervention group
Group type: COMPARATOR
Intervention: Manual small-incision cataract surgery
Number of subjects: 200
Study 21152831 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein plus exercise (G1)
Number of subjects: 60
Study 21152831 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo plus exercise (G2)
Number of subjects: 60
Study 21152831 — intervention group
Group type: COMPARATOR
Intervention: Placebo and no exercise (G4)
Number of subjects: 60
Study 18849624 — intervention group
Group type: EXPERIMENTAL
Intervention: Würzburg bleb classification score (WBCS)
Number of subjects: 104
Study 18849624 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean of all 3 raters using WBCS
Number of subjects: 104
Study 16433601 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment (acetaminophen 650 mg every 6 h for temperature >38.5 degrees C and cooling blanket for temperature >39.5 degrees C)
Number of subjects: 82
Study 16433601 — intervention group
Group type: COMPARATOR
Intervention: Permissive treatment (no treatment for temperature >38.5 degrees C, treatment initiated at temperature >40 degrees C with acetaminophen and cooling blankets)
Number of subjects: 82
Study 16433601 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive treatment
Number of subjects: 82
Study 16433601 — intervention group
Group type: COMPARATOR
Intervention: Permissive treatment
Number of subjects: 82
Study 14597105 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN)-beta-1a (Rebif(R)) therapy for 1 year
Number of subjects: 0
Study 14597105 — intervention group
Group type: COMPARATOR
Intervention: Prior to treatment
Number of subjects: 0
Study 10595630 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 50 mg/od
Number of subjects: 62
Study 10595630 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/od
Number of subjects: 62
Study 10595630 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel 100 mg/od
Number of subjects: 62
Study 10595630 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine 250 mg/bid
Number of subjects: 62
Study 8911882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride 50 mg
Number of subjects: 18
Study 8911882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride 200 mg
Number of subjects: 18
Study 8911882 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (0.8 g/kg)
Number of subjects: 18
Study 8911882 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride 50 mg and 200 mg
Number of subjects: 18
Study 1988333 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy
Number of subjects: 99
Study 1988333 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy (in alcoholic patients)
Number of subjects: 99
Study 1988333 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic patients
Number of subjects: 99
Study 1988333 — intervention group
Group type: COMPARATOR
Intervention: Large varices
Number of subjects: 99
Study 1988333 — intervention group
Group type: COMPARATOR
Intervention: Wedged hepatic vein pressure < 12 mm Hg
Number of subjects: 99
Study 1988333 — intervention group
Group type: COMPARATOR
Intervention: Elective sclerotherapy
Number of subjects: 99
Study 6108756 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta-blockers (atenolol and propranolol) combined with topical epinephrine
Number of subjects: 0
Study 6108756 — intervention group
Group type: COMPARATOR
Intervention: Timolol (local beta-blocker)
Number of subjects: 0
Study 6108756 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol combined with epinephrine eyedrops
Number of subjects: 0
Study 30778688 — intervention group
Group type: COMPARATOR
Intervention: Diode laser (940 nm for 1 min)
Number of subjects: 17
Study 30778688 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (2780 nm, pulse width 140-200 μs)
Number of subjects: 17
Study 25348661 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon (Peg-IFN) add-on therapy (180 µg/week)
Number of subjects: 175
Study 25348661 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV) monotherapy (0.5 mg/day)
Number of subjects: 175
Study 25348661 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon (Peg-IFN) add-on therapy
Number of subjects: 175
Study 25348661 — intervention group
Group type: COMPARATOR
Intervention: Entecavir (ETV) monotherapy
Number of subjects: 175
Study 23600919 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-gauge needle (25G)
Number of subjects: 188
Study 23600919 — intervention group
Group type: COMPARATOR
Intervention: 22-gauge needle (22G)
Number of subjects: 188
Study 17413102 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid skim milk
Number of subjects: 0
Study 17413102 — intervention group
Group type: COMPARATOR
Intervention: Soy-protein beverage
Number of subjects: 0
Study 15323413 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic consultation
Number of subjects: 36
Study 11240877 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia (B)
Number of subjects: 60
Study 11240877 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous breathing (S)
Number of subjects: 60
Study 9447901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin for seven days, 500 mg b.i.d. (Group 1, 25 patients)
Number of subjects: 50
Study 9447901 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin for ten days, 750 mg b.i.d. (Group 2, 25 patients)
Number of subjects: 50
Study 9447901 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study 8514551 — intervention group
Group type: EXPERIMENTAL
Intervention: 75.6 CGE (50.4 Gy by 107-25 MV photons + 25.2 CGE by protons)
Number of subjects: 191
Study 8514551 — intervention group
Group type: COMPARATOR
Intervention: 67.2 CGE (10-25 MV photons)
Number of subjects: 191
Study 2881038 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (20 mg/kg intramuscularly daily for the first 3 days of life)
Number of subjects: 231
Study 2881038 — intervention group
Group type: COMPARATOR
Intervention: Control (no vitamin E supplementation)
Number of subjects: 231
Study 30784636 — intervention group
Group type: EXPERIMENTAL
Intervention: Alive & Thrive initiative
Number of subjects: 2288
Study 30784636 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2288
Study 29791011 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Methotrexate (MTX)
Number of subjects: 187
Study 29791011 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 187
Study 27068332 — intervention group
Group type: EXPERIMENTAL
Intervention: Barnidipine + losartan
Number of subjects: 151
Study 27068332 — intervention group
Group type: COMPARATOR
Intervention: Lercanidipine + losartan
Number of subjects: 151
Study 25196897 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FVIII Fc fusion protein (rFVIIIFc) individualized prophylaxis
Number of subjects: 96
Study 25196897 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant FVIII Fc fusion protein (rFVIIIFc) weekly prophylaxis
Number of subjects: 96
Study 25196897 — intervention group
Group type: COMPARATOR
Intervention: Standard FVIII regimen (pre-study)
Number of subjects: 96
Study 25196897 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated dosing regimens for rFVIIIFc
Number of subjects: 96
Study 21666531 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant Flow nasal continuous positive airway pressure
Number of subjects: 276
Study 21666531 — intervention group
Group type: COMPARATOR
Intervention: Constant flow nasal continuous positive airway pressure
Number of subjects: 276
Study 20716819 — intervention group
Group type: EXPERIMENTAL
Intervention: REAC-CRM therapy
Number of subjects: 888
Study 20716819 — intervention group
Group type: COMPARATOR
Intervention: Placebo REAC-CRM therapy
Number of subjects: 888
Study 17935749 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term adaptation (5s) to a female face
Number of subjects: 0
Study 17935749 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term adaptation (500 ms) to a female face
Number of subjects: 0
Study 17935749 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term adaptation (5s)
Number of subjects: 0
Study 17935749 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term adaptation (500 ms)
Number of subjects: 0
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascending series of contact heat stimuli rated for pain intensity (VAS-I)
Number of subjects: 175
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascending series of contact heat stimuli rated for unpleasantness (VAS-A)
Number of subjects: 175
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Random series of contact heat stimuli rated for pain intensity (VAS-I)
Number of subjects: 175
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Random series of contact heat stimuli rated for unpleasantness (VAS-A)
Number of subjects: 175
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall variance in pain ratings
Number of subjects: 175
Study 16298065 — intervention group
Group type: EXPERIMENTAL
Intervention: Model fit for curve fitting
Number of subjects: 175
Study 12046340 — intervention group
Group type: EXPERIMENTAL
Intervention: Symmetrical left ventricular hypertrophy (group I)
Number of subjects: 47
Study 12046340 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetrical left ventricular hypertrophy (group II)
Number of subjects: 47
Study 12046340 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 healthy subjects, group III)
Number of subjects: 47
Study 12046340 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 47
Study 10439882 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinapril
Number of subjects: 105
Study 10439882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 7812559 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (200 mg)
Number of subjects: 8
Study 7812559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2128472 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (CAE)
Number of subjects: 311
Study 2128472 — intervention group
Group type: COMPARATOR
Intervention: Procaine penicillin (PP)
Number of subjects: 311
Study 498954 — intervention group
Group type: EXPERIMENTAL
Intervention: Transluminal recanalization of occluded coronary artery
Number of subjects: 10
Study 31113841 — intervention group
Group type: EXPERIMENTAL
Intervention: Onalespib (220 mg/m2 once weekly for 3 of 4 weeks) + Abiraterone Acetate + Prednisone/Prednisolone
Number of subjects: 48
Study 31113841 — intervention group
Group type: EXPERIMENTAL
Intervention: Onalespib (120 mg/m2 on day 1 and day 2 weekly for 3 of 4 weeks) + Abiraterone Acetate + Prednisone/Prednisolone
Number of subjects: 48
Study 28600160 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based, multi-component intervention including anticipatory guidance on breastfeeding, responsive feeding, non-food soothing techniques, complementary feeding, infant sleep, and minimizing TV/media, delivered through 6 home visits, 4 newsletters, and twice-weekly text messaging.
Number of subjects: 468
Study 28600160 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based, multi-component intervention
Number of subjects: 468
Study 28600160 — intervention group
Group type: COMPARATOR
Intervention: Child safety attention-control group
Number of subjects: 468
Study 25619685 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 30
Study 25619685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 24013703 — intervention group
Group type: EXPERIMENTAL
Intervention: DC fibber
Number of subjects: 14
Study 24013703 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst fibber
Number of subjects: 14
Study 24013703 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock-on-T
Number of subjects: 14
Study 22619904 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene bag
Number of subjects: 38
Study 22619904 — intervention group
Group type: COMPARATOR
Intervention: Standard thermal care (control)
Number of subjects: 38
Study 19349551 — intervention group
Group type: EXPERIMENTAL
Intervention: Presurgical stress management intervention (SM)
Number of subjects: 159
Study 19349551 — intervention group
Group type: COMPARATOR
Intervention: Supportive attention group (SA)
Number of subjects: 159
Study 19349551 — intervention group
Group type: COMPARATOR
Intervention: Standard care group (SC)
Number of subjects: 159
Study 17210431 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair with subacromial decompression
Number of subjects: 80
Study 17210431 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic rotator cuff repair without subacromial decompression
Number of subjects: 80
Study 15045534 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary standardized tape hypnosis
Number of subjects: 50
Study 15045534 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (only local anesthesia)
Number of subjects: 50
Study 11523668 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic implantation of human neuronal cells
Number of subjects: 12
Study 11523668 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET
Number of subjects: 12
Study 9933837 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP (Transurethral Prostatic Resection)
Number of subjects: 57
Study 9933837 — intervention group
Group type: EXPERIMENTAL
Intervention: TULP (Transurethral Laser Prostatectomy)
Number of subjects: 57
Study 9933837 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 patients with bladder cancer undergoing transurethral resection and laser ablation)
Number of subjects: 57
Study 7925207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg‐1 immediately prior to thiopentone
Number of subjects: 80
Study 7925207 — intervention group
Group type: COMPARATOR
Intervention: Rocuronium 0.6 mg kg‐1 immediately after thiopentone
Number of subjects: 80
Study 7925207 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.04 mg kg‐1 prior to induction
Number of subjects: 80
Study 7925207 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium 1.5 mg kg‐1 immediately after thiopentone
Number of subjects: 80
Study 3045451 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric antibiotic treatment
Number of subjects: 0
Study 3045451 — intervention group
Group type: COMPARATOR
Intervention: Open lung biopsy
Number of subjects: 0
Study 29479070 — intervention group
Group type: EXPERIMENTAL
Intervention: Major molecular remission (MMR)
Number of subjects: 0
Study 29479070 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% BCR-ABL response
Number of subjects: 0
Study 29479070 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep molecular remission
Number of subjects: 0
Study 29479070 — intervention group
Group type: EXPERIMENTAL
Intervention: Early achievement of MMR
Number of subjects: 0
Study 27759808 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance modified electroconvulsive therapy (MECT) combined with risperidone
Number of subjects: 62
Study 27759808 — intervention group
Group type: COMPARATOR
Intervention: Risperidone only
Number of subjects: 62
Study 25662558 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN) of trigger points in the lateral pterygoid muscle
Number of subjects: 48
Study 25662558 — intervention group
Group type: COMPARATOR
Intervention: Methocarbamol/paracetamol combination treatment
Number of subjects: 48